[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2093945T3 - Composicion para el tratamiento del acne que contiene al menos un derivado de acido salicilico. - Google Patents

Composicion para el tratamiento del acne que contiene al menos un derivado de acido salicilico.

Info

Publication number
ES2093945T3
ES2093945T3 ES93402077T ES93402077T ES2093945T3 ES 2093945 T3 ES2093945 T3 ES 2093945T3 ES 93402077 T ES93402077 T ES 93402077T ES 93402077 T ES93402077 T ES 93402077T ES 2093945 T3 ES2093945 T3 ES 2093945T3
Authority
ES
Spain
Prior art keywords
derivative
radical
composition
formula
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93402077T
Other languages
English (en)
Inventor
Henri Sebag
Alain Ribier
Pascal Simon
Laurence Sebillotte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2093945T3 publication Critical patent/ES2093945T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSICION PARA EL TRATAMIENTO DEL ACNE QUE CONTIENE UNA DISPERSION DE VESICULAS DE LIPIDOS AMFIFILOS IONICOS O NO IONICOS, LAS VESICULAS CONTIENEN EN LA FASE LIPIDICA AL MENOS UN DERIVADO DEL ACIDO SALICILICO DE FORMULA (I), EN LA CUAL R REPRESENTA UN RADICAL ALQUILO LINEAL O RAMIFICADO EN C11-C17, R''1, R''2, R''3 IDENTICOS O DIFERENTES REPRESENTAN UN RADICAL ALQUILO O HIDROXIALQUILO EN C1-C18, UNO DE LOS RADICALES R''1, R''2 O R''3 PUEDE SER UN RADICAL BENCILO. EL DERIVADO DE FORMULA (I) SIRVE A LA VEZ DE LIPIDO CARGADO Y DE ACTIVO ANTIACNE. LOS DERIVADOS DE FORMULA (I) EN LOS CUALES CUANDO R REPRESENTA UN RADICAL ALQUILO EN C13-C17, R''1, R''2, R''3 CUANDO SON IDENTICOS, NO REPRESENTAN UN RADICAL HIDROXIETILO.
ES93402077T 1992-08-24 1993-08-20 Composicion para el tratamiento del acne que contiene al menos un derivado de acido salicilico. Expired - Lifetime ES2093945T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9210227A FR2694934B1 (fr) 1992-08-24 1992-08-24 Composition pour le traitement de l'acné contenant un dérivé d'acide salicylique et dérivés d'acide salicylique.

Publications (1)

Publication Number Publication Date
ES2093945T3 true ES2093945T3 (es) 1997-01-01

Family

ID=9432988

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93402077T Expired - Lifetime ES2093945T3 (es) 1992-08-24 1993-08-20 Composicion para el tratamiento del acne que contiene al menos un derivado de acido salicilico.

Country Status (10)

Country Link
US (1) US5411742A (es)
EP (1) EP0585170B1 (es)
JP (1) JPH06183949A (es)
AT (1) ATE144977T1 (es)
CA (1) CA2104635C (es)
DE (1) DE69305808T2 (es)
DK (1) DK0585170T3 (es)
ES (1) ES2093945T3 (es)
FR (1) FR2694934B1 (es)
GR (1) GR3022348T3 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9414572D0 (en) * 1994-07-19 1994-09-07 Unilever Plc Soap composition
FR2726468B1 (fr) * 1994-11-03 1996-12-13 Oreal Utilisation de derive de l'acide salicylique comme stabilisant d'une emulsion huile-dans-eau
US5560917A (en) * 1995-02-01 1996-10-01 Maybelline Intermediate Company Cosmetic makeup composition
US6221847B1 (en) 1996-09-13 2001-04-24 Clemson University Composition and method for treating bacterial infection
CA2265521C (en) * 1996-09-13 2009-06-09 Clemson University Anti-bacterial composition for treating acne
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
JP3211740B2 (ja) * 1997-08-28 2001-09-25 ダイキン工業株式会社 化粧料
US6017549A (en) * 1997-09-30 2000-01-25 E-L Management Corp. Non-irritating cosmetic and pharmaceutical compositions
US8093293B2 (en) * 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US6251425B1 (en) 1998-10-02 2001-06-26 Igen, Inc. Glucoside paucilamellar vesicles
US20020197244A1 (en) * 1998-12-07 2002-12-26 Miri Seiberg Compositions and methods for regulating phagocytosis and ICAM-1 expression
US6190716B1 (en) * 1999-02-17 2001-02-20 Scott O. Galbreath, Jr. Method for preparing a grape derived product
DE19919481A1 (de) * 1999-04-29 2000-11-02 Beiersdorf Ag Stabile, gegen unreine Haut und gegen Akne wirksame Wirkstoffkombinationen mit einem Gehalt an grenzflächenaktiven Glucosederivaten und Hydroxycarbonsäuren
US20040235950A1 (en) * 1999-05-20 2004-11-25 Voorhees John J. Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
US7268148B2 (en) * 1999-05-20 2007-09-11 Regents Of The University Of Michigan Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
WO2001000158A1 (en) * 1999-06-28 2001-01-04 The Procter & Gamble Company Cosmetic compositions containing quaternary ammonium compounds
JP4408994B2 (ja) * 1999-07-13 2010-02-03 Ａｚエレクトロニックマテリアルズ株式会社 低誘電率多孔質シリカ質膜、半導体装置およびコーティング組成物
US7985404B1 (en) * 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) * 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
GB0004686D0 (en) * 2000-02-28 2000-04-19 Aventis Pharma Ltd Chemical compounds
FR2808191B1 (fr) * 2000-04-28 2004-03-05 Oreal Extrait de vegetal de l'espece olea europaea comme inhibiteur de no-synthase et utilisations
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
US8431550B2 (en) * 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US20020142013A1 (en) * 2001-01-31 2002-10-03 Maes Daniel H. Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
US7192615B2 (en) * 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
JP4786868B2 (ja) * 2001-11-02 2011-10-05 ザ プロクター アンド ギャンブル カンパニー 陽イオン性ポリマー及び水不溶性固体物質を含有する組成物
US20030224075A1 (en) * 2002-02-21 2003-12-04 Jue-Chen Liu Soy composition for balancing combination skin
US20040063593A1 (en) * 2002-09-30 2004-04-01 Wu Jeffrey M. Compositions containing a cosmetically active organic acid and a legume product
WO2004066970A1 (en) * 2003-01-27 2004-08-12 The Procter & Gamble Company Personal cleansing composition containing irregularly shaped particles and spherical particles
US20050014730A1 (en) * 2003-04-02 2005-01-20 Carlson Robert M. Anti-fungal formulation of triterpene and essential oil
US20050004561A1 (en) * 2003-07-01 2005-01-06 Lynn Halas Method for removing hair
FR2857266B1 (fr) * 2003-07-07 2007-09-21 Jean Noel Thorel Composition a usage dermatologique et/ou cosmetique, comprenant a titre de principe actif au moins un antioxydant lipophile
US7198807B2 (en) * 2003-12-01 2007-04-03 Triarco Industries, Inc. Inhibition of P. acnes using botanical extracts
US20070224153A1 (en) * 2006-03-16 2007-09-27 Librizzi Joseph J High-deposition compositions and uses thereof
US20070218029A1 (en) * 2006-03-16 2007-09-20 Librizzi Joseph J High-deposition compositions and uses thereof
CN100444288C (zh) * 2006-07-21 2008-12-17 暨南大学 纳米孔型聚甲基硅氧烷低介电常数材料及其制备方法和应用
US9616006B2 (en) * 2007-10-10 2017-04-11 DermaMedics, LLC Methods and compositions for treating dermatological diseases and conditions
US10251839B2 (en) * 2008-01-22 2019-04-09 Igi Laboratories, Inc. Lipid vesicles derived from olive oil fatty acids
EP2839834B1 (fr) 2013-08-19 2018-01-17 Rachid Ennamany Composition dermatologique à partir de cellules végétales souches et d'un dérivé d'acide salicylique.
US10449129B2 (en) 2015-02-20 2019-10-22 Biocogent, Llc Encapsulates of salicylic acid and polysalicylic acid derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897308A (en) * 1975-06-30 1990-01-30 L'oreal Compositions comprising aqueous dispersions of lipid spheres
US4514385A (en) * 1981-10-05 1985-04-30 Alcon Laboratories, Inc. Anti-acne compositions
US4499295A (en) * 1983-05-09 1985-02-12 G. D. Searle & Co. Protease inhibitors
FR2607498B1 (fr) * 1986-12-01 1991-04-05 Oreal Nouveaux salicylates lipophiles d'ammoniums quaternaires, leur utilisation en cosmetique et en dermopharmacie
FR2623395B1 (fr) * 1987-11-24 1990-04-20 Oreal Compositions pharmaceutiques et cosmetiques a base de peroxyde de benzoyle et de salicylates lipophiles d'ammonium quaternaires et leur utilisation, notamment dans le traitement de l'acne

Also Published As

Publication number Publication date
CA2104635A1 (fr) 1994-02-25
JPH06183949A (ja) 1994-07-05
ATE144977T1 (de) 1996-11-15
EP0585170A1 (fr) 1994-03-02
FR2694934B1 (fr) 1994-11-10
US5411742A (en) 1995-05-02
CA2104635C (fr) 2004-11-23
DE69305808T2 (de) 1997-03-13
DE69305808D1 (de) 1996-12-12
GR3022348T3 (en) 1997-04-30
DK0585170T3 (da) 1996-11-25
EP0585170B1 (fr) 1996-11-06
FR2694934A1 (fr) 1994-02-25

Similar Documents

Publication Publication Date Title
ES2093945T3 (es) Composicion para el tratamiento del acne que contiene al menos un derivado de acido salicilico.
SE7906026L (sv) Metafenylendiaminer och fergkompositioner, som innehaller dessa foreningar
DE59710082D1 (de) Kosmetische Präparate in Form einer Nanodispersion
DK0679157T3 (da) Nye 3,4-diarylthiophener og analoge deraf til anvendelse som antiinflammatoriske midler
PT772600E (pt) Compostos de imidazolilo substituido nas posicoes 1 e 2 para o tratamento da inflamacao
KR890011601A (ko) (사이클로알킬아미노)메틸렌비스(포스폰산)및 활성성분으로서 이를 함유한 의약
ES2114645T3 (es) Utilizacion de un fosfato de alfa-tocoferol, o de uno de sus derivados para la preparacion de una composicion cosmetica, dermatologica o farmaceutica, de actividad anti-radicalar; composicion asi obtenida.
ES2114931T3 (es) Nuevos esteres esteroidales.
DK0663902T3 (da) 25-carboxylsyrederivater i vitamin D-rækken, farmaceutiske præparater indeholdende disse derivater samt deres anvendelse ti
BR9204316A (pt) Formulacao de agentes de branqueamento estavel ao armazenamento,processo para a preparacao da formulacao e aplicacao
AR004672A1 (es) Derivados de la banzo(g)quinolina, proceso para prepararlos,su utilizacion como productos farmaceuticos, las composiciones farmaceuticas que los contieneny los metodos de tratamiento de la depresion, ansiedad y desordenes bipolares que utilizan dichos compuestos.
ES2113664T3 (es) Derivados de aminoacidos como inhibidores de la no sintasa.
BR9201854A (pt) Composto derivado de pridazinas,processo para sua preparacao,e,composicao farmaceutica
ES2063309T3 (es) Derivados de pirimidina 3-oxido halogenados, su utilizacion para el tratamiento y la prevencion de la caida de los cabellos y para estimular su crecimiento.
ATE217183T1 (de) Stabile kosmetische und dermatologische lichtschutzzubereitungen in form von w/o- emulsionen mit einem gehalt an anorganischen mikropigmenten, triazinderivaten und/oder weiteren komponenten
BR9404456A (pt) Aplicação de ésteres de ácido fosfórico e processo para o impedimento da cristalização de substâncias ativas
ES2133511T3 (es) Composicion tintorea que contiene p-fenilendiaminas con azufre, p-fenilendiaminas con azufre y su procedimiento de preparacion.
ES2098570T3 (es) Amidas de un acido 4-amino-2-ureido-pirimidina-5-carboxilico, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su utilizacion.
PT89082A (pt) Processo para a preparacao de novos derivados n-(23-vinblastinoilicos)do acido 1-amino-metilfosfonico
ES513336A0 (es) "procedimiento para la preparacion de concentrados liquidos de agentes desinfectantes".
ES2072765T3 (es) Procedimiento para la obtencion de 5,6-dihidroxi-indolinas.
NO158622C (no) Analogifremgangsmaate for fremstilling av benzosyrederivater med antimikrobiell aktivitet.
ATE215934T1 (de) Neue histidinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel gegen freie radikale
SE7904543L (sv) Nya joniska bensen-polyjodidderivat for anvendning som kontrastmedel vid rontgenbehandling
FI910159A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9a-hydroxi-3-oxo-4,24(25)-stigmastadien-26 -syraderivat.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 585170

Country of ref document: ES